<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.5.1//EN" "ep-patent-document-v1-5-1.dtd">
<ep-patent-document id="EP19888596A1" file="19888596.4" lang="en" country="EP" doc-number="3886871" kind="A1" date-publ="20211006" status="n" dtd-version="ep-patent-document-v1-5-1"><!-- This XML data has been generated under the supervision of the European Patent Office --><SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORSMESMMAKHTNMD..........</B001EP><B003EP>*</B003EP><B005EP>X</B005EP><B007EP>BDM Ver 2.0.12 (4th of August) -  1100000/0</B007EP></eptags></B000><B100><B110>3886871</B110><B130>A1</B130><B140><date>20211006</date></B140><B190>EP</B190></B100><B200><B210>19888596.4</B210><B220><date>20191127</date></B220><B240><B241><date>20210603</date></B241></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>201862773388 P</B310><B320><date>20181130</date></B320><B330><ctry>US</ctry></B330><B310>201816225210</B310><B320><date>20181219</date></B320><B330><ctry>US</ctry></B330><B310>201916409543</B310><B320><date>20190510</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20211006</date><bnum>202140</bnum></B405><B430><date>20211006</date><bnum>202140</bnum></B430></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  35/16        20150101AFI20200605BHEP        </text></classification-ipcr></B510EP><B520EP><classifications-cpc><classification-cpc sequence="1"><text>A61K  35/16        20130101 LI20200626BHEP        </text></classification-cpc></classifications-cpc></B520EP><B540><B541>de</B541><B542>VERFAHREN ZUR BEHANDLUNG VON LIPIDBEDINGTEN KRANKHEITEN, EINSCHLIESSLICH XANTHOMEN, KAROTISSTENOSEN UND ZEREBRALER ATHEROSKLEROSE</B542><B541>en</B541><B542>METHODS FOR TREATING LIPID-RELATED DISEASES INCLUDING XANTHOMAS, CAROTID ARTERY STENOSES, AND CEREBRAL ATHEROSCLEROSIS</B542><B541>fr</B541><B542>MÉTHODES DE TRAITEMENT DE MALADIES LIÉES AUX LIPIDES, Y COMPRIS LES XANTHOMAS, LES STÉNOSES DES ARTÈRES CAROTIDES ET L'ATHÉROSCLÉROSE CÉRÉBRALE</B542></B540></B500><B700><B710><B711><snm>HDL Therapeutics, Inc.</snm><iid>101497376</iid><irf>P239974.EP.01/THOMR</irf><adr><str>601 21st Street, Suite 300</str><city>Vero Beach, FL 32960</city><ctry>US</ctry></adr></B711></B710><B720><B721><snm>BREWER, Hollis, Bryan, Jr.</snm><adr><str>11410 River Road</str><city>Potomac, MD 20854</city><ctry>US</ctry></adr></B721><B721><snm>MATIN, Michael, M.</snm><adr><str>95 South Terrace</str><city>Short Hills, NJ 07078</city><ctry>US</ctry></adr></B721></B720><B740><B741><snm>Murgitroyd &amp; Company</snm><iid>101691439</iid><adr><str>Murgitroyd House 
165-169 Scotland Street</str><city>Glasgow G5 8PL</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AL</ctry><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MK</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>RS</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>SM</ctry><ctry>TR</ctry></B840><B844EP><B845EP><ctry>BA</ctry></B845EP><B845EP><ctry>ME</ctry></B845EP></B844EP><B848EP><B849EP><ctry>KH</ctry></B849EP><B849EP><ctry>MA</ctry></B849EP><B849EP><ctry>MD</ctry></B849EP><B849EP><ctry>TN</ctry></B849EP></B848EP><B860><B861><dnum><anum>US2019063659</anum></dnum><date>20191127</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2020113041</pnum></dnum><date>20200604</date><bnum>202023</bnum></B871></B870></B800></SDOBI></ep-patent-document>